— Know what they know.
Not Investment Advice

CDNA NASDAQ

CareDx, Inc
1W: +1.9% 1M: +9.2% 3M: +99.2% YTD: +268.5% 1Y: +371.1% 3Y: +1228.2% 5Y: -4.2%
$70.53
+1.43 (+2.07%)
 
Weekly Expected Move ±7.1%
$59 $64 $69 $74 $79
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Buy · Power 70 · $3.6B mcap · 49M float · 2.52% daily turnover · Short 53% of daily vol
Credit Risk of going bust: lower than 74% of companies Debt: 0.5% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.05 (down 99.9%), CareDx, Inc would be worth roughly what it owes.
Total debt $19.2M against a stock market value of $3.65B.
Distance to default 8.43 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $9.6M (short-term plus half of long-term), stock volatility 68.4%; Altman Z'' 5.20. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Supply Chain Overview

2 relationships
2
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-04-15
Earliest Filing
2023-04-03
Latest Filing
partner: 2

Counterparties (Filed by CDNA)

2 relationships

Companies named in CDNA's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Stanford University — partner Licensee of patents under an exclusive agreement amended to address royalty payments and legal fees for a Supreme Court 2023-04-03 View
Jefferies LLC JEF partner Sales agent for the offering of up to $200,000,000 in shares of CareDx, Inc. common stock. 2022-04-15 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-16 Acquisition/Disposition; Exhibits Acquisition View
2026-07-30 Earnings Release; Regulation FD; Exhibits View
2026-07-07 Acquisition/Disposition; Regulation FD; Exhibits Acquisition View
2026-06-15 Officer/Director Change; Shareholder Vote; Exhibits View
2026-04-28 Material Agreement; Earnings Release; Regulation FD; Other Events; Exhibits Agreement View
2026-04-23 Officer/Director Change View
2026-04-16 Material Agreement; Earnings Release; Regulation FD; Exhibits Agreement View
2026-02-25 Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic View
2026-02-24 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2026-01-12 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-12-18 Other Events View
2025-12-15 Amendments to Articles of Incorporation or Bylaws View
2025-11-04 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2025-10-24 Departure/Election of Directors; Appointment of Officers View
2025-08-06 Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic View
2025-06-12 Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit View
2025-06-03 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-04-30 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-03-28 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-02-26 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms